BioCentury
ARTICLE | Company News

QR Pharma, Michael J. Fox Foundation For Parkinson's Research neurology news

March 12, 2012 7:00 AM UTC

QR Pharma received a $468,000 grant from the foundation to develop Posiphen to treat Parkinson's disease. QR Pharma will conduct preclinical studies of the amyloid precursor protein (APP) translation ...